Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Receivables - Net: 2022-2024

Historic Receivables - Net for Autolus Therapeutics (AUTL) over the last 3 years, with Dec 2024 value amounting to $15,000.

  • Autolus Therapeutics' Receivables - Net was N/A to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year change of. This contributed to the annual value of $15,000 for FY2024, which is 86.24% down from last year.
  • As of FY2024, Autolus Therapeutics' Receivables - Net stood at $15,000, which was down 86.24% from $109,000 recorded in FY2023.
  • Autolus Therapeutics' 5-year Receivables - Net high stood at $121,000 for FY2022, and its period low was $15,000 during FY2024.
  • Over the past 3 years, Autolus Therapeutics' median Receivables - Net value was $109,000 (recorded in 2023), while the average stood at $81,667.
  • Data for Autolus Therapeutics' Receivables - Net shows a maximum YoY tumbled of 86.24% (in 2024) over the last 5 years.
  • Over the past 3 years, Autolus Therapeutics' Receivables - Net (Yearly) stood at $121,000 in 2022, then fell by 9.92% to $109,000 in 2023, then tumbled by 86.24% to $15,000 in 2024.